Awards & Accolades 7 November

Donita C. Brady
Donita C. Brady, PhD

Donita C. Brady, PhD, the Harrison McCrea Dickson, MD, and Clifford C. Baker, MD, Presidential Professor in Cancer Biology, has been named to The Pew Charitable Trusts' 2023 class of Innovation Fund investigators. Brady, a 2016 Pew biomedical scholar, will team up with Kivanç Birsoy, PhD, of The Rockefeller University, to identify cell components that regulate-or respond to-transition metals, key dietary nutrients that maintain health in humans and other organisms.


Yanxiang Deng
Yanxiang Deng, PhD

Yanxiang Deng, PhD, an assistant professor of Pathology and Laboratory Medicine, has been awarded a 2023 Packard Fellowship for Science and Engineering. As a member of the 35th Anniversary class of fellows, Deng will receive $875,000 over five years to pursue his research, which focuses on developing new tools at the intersection of microchip, microscopy, and genomics to study tissue complexity.


Oluwadamilola
Oluwadamilola "Lola" Fayanju, MD, MA, MPHS

Oluwadamilola "Lola" Fayanju, MD, MA, MPHS, the Helen O. Dickens Presidential Associate Professor and chief of the Breast Surgery Division, has been named a Breast Cancer Research Foundation (BCRF) Investigator. She was awarded $225,000 for her research to identify and address factors that contribute to racial disparities in breast cancer outcomes that add to treatment delays or decrease treatment adherence.


Carl June
Carl June, MD

Carl June, MD, the Richard W. Vague Professor in Immunotherapy, has been named a recipient of the 2023 "Lombardy is Research" Prize for the development of immunotherapy with natural and genetically modified cells. The award recognizes significant research, discoveries, and socially impactful inventions in the field of life science with a specific focus on "Innovative Models of Care, Therapy, and Prevention." Winners share a €1,000,000 prize.


Roy Rosin, chief innovation officer, has been selected for Becker's Healthcare's list of Hospital and Health System Chief Innovation Officers to Know in 2023. In this role since 2012, Rosin is charged with identifying, shaping, and implementing improvements in patient health outcomes and patient experience while also testing for potential new revenue streams.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.